Targeted therapies in small cell lung cancer (Review)

被引：27

作者：

Lu, Hong-Yang ^{[1
]}

Wang, Xiao-Jia ^{[1
]}

Mao, Wei-Min ^{[1
]}

机构：

[1] Zhejiang Canc Hosp, Zhejiang Key Lab Diag & Treatment Technol Thorac, Hangzhou 310022, Zhejiang, Peoples R China

来源：

ONCOLOGY LETTERS | 2013年 / 5卷 / 01期

关键词：

small cell lung cancer; targeted therapy; epidermal growth factor receptor; vascular endothelial growth factor; apoptosis; gene; GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; BCL-2 ANTISENSE OLIGONUCLEOTIDE; C-KIT; ADJUVANT VACCINATION; RESPONDING PATIENTS; IMATINIB MESYLATE; EGFR MUTATION; DOUBLE-BLIND; CHEMOTHERAPY;

D O I：

10.3892/ol.2012.791

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer is the leading cause of cancer-related mortality. Small cell lung cancer (SCLC) accounted for 12.95% of all lung cancer histological types in 2002. Despite trends toward modest improvement in survival, the outcome remains extremely poor. Chemotherapy is the cornerstone of treatment in SCLC. More than two-thirds of patients who succumb to lung cancer in the United States are over 65 years old. Elderly patients tolerate chemotherapy poorly and need novel therapeutic agents. Targeted drugs have less toxicity than chemotherapy drugs, but no targeted agents have been approved for use in the treatment of SCLC patients to date. Certain new targeted agents, including gefitinib, bevacizumab and Bcl-2 inhibitors, offer a promise of improved outcomes, however negative results are more commonly reported than positive. This review focuses on targeted therapies in SCLC.

引用

页码：3 / 11

页数：9

共 50 条

[21] Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives [J].

Minguet, Joan ;

Smith, Katherine H. ;

Bramlage, Peter .

INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (11) :2549-2561

[22] Emerging therapies for small cell lung cancer [J].

Sen Yang ;

Zhe Zhang ;

Qiming Wang .

Journal of Hematology & Oncology, 12

[23] Emerging therapies for small cell lung cancer [J].

Yang, Sen ;

Zhang, Zhe ;

Wang, Qiming .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)

[24] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC) [J].

Moya-Horno, Irene ;

Viteri, Santiago ;

Karachaliou, Niki ;

Rosell, Rafael .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10

[25] Targeted Therapy and Immune Therapy for Small Cell Lung Cancer [J].

Gadgeel, Shirish M. .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)

[26] Targeted therapy for small cell lung cancer [J].

Apar Kishor Ganti ;

Amit W. Panwalkar .

Targeted Oncology, 2007, 2 :89-97

[27] Targeted therapy for small cell lung cancer [J].

Ganti, Apar Kishor ;

Panwalkar, Amit W. .

TARGETED ONCOLOGY, 2007, 2 (02) :89-97

[28] Targeted therapies for non-small cell lung cancer [J].

Papaetis, G. S. ;

Roussos, C. ;

Syrigos, K. N. .

CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (27) :2810-2831

[29] Targeted therapies in non-small cell lung cancer [J].

Kyle, Fiona ;

Spicer, James .

CANCER IMAGING, 2008, 8 (01) :199-205

[30] Targeted therapies for non-small cell lung cancer [J].

Spicer, J ;

Harper, P .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (09) :1055-1062

← 1 2 3 4 5 →